Marty A, Glitsch M, Kondo S, Llano I
Max-Planck-Institut für biophysikalische Chemie, Arbeitsgruppe Zelluläre Neurobiologie, Göttingen, Germany.
J Physiol Paris. 1996;90(5-6):327-8. doi: 10.1016/s0928-4257(97)87909-0.
We have investigated the effects of agents interfering with the cAMP pathway on the rate of miniature IPSCs in cerebellar slices. Noradrenaline and group II glutamate metabotropic receptor agonists respectively enhance and reduce the rate of miniature IPSCs, presumably because they respectively increase and decrease the presynaptic concentration of cAMP.